Ilex paraguariensis and its main component chlorogenic acid inhibit fructose formation of advanced glycation endproducts with amino acids at conditions compatible with those in the digestive system

Fitoterapia

Volumn 117, Issue , 2017, Pages 6-10

  Bains, Yasmin ^a   Gugliucci, Alejandro ^a  

^a Touro University California   (United States)

Author keywords

Advanced glycation; Agave syrup; Asthma; Chlorogenic acid; Fructose; Fructositis; High fructose corn syrup; Ilex paraguariensis; Inflammation; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID; AMINOGUANIDINE; ARGININE; CAFFEIC ACID; CHLOROGENIC ACID; FRUCTOSE; GLUCOSE; GLYCINE; ILEX PARAGUARIENSIS EXTRACT; LYSINE; NEOCHLOROGENIC ACID; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIOXIDANT; PHENOL DERIVATIVE;

ARTICLE; DIGESTIVE SYSTEM; DRUG POTENCY; FLUORESCENCE ANALYSIS; IC50; ILEX PARAGUARIENSIS; INTESTINE; MATE TEA; PH; PRIORITY JOURNAL; TEMPERATURE; TIME; BEVERAGE; CHEMISTRY;

AMINO ACIDS; ANTIOXIDANTS; BEVERAGES; CHLOROGENIC ACID; DIGESTIVE SYSTEM; FRUCTOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; ILEX PARAGUARIENSIS; PHENOLS; PLANT EXTRACTS;

EID: 85007349335     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.12.006     Document Type: Article

References (36)

1. [1] Rodriguez, L.A., Madsen, K.A., Cotterman, C., Lustig, R.H., Added sugar intake and metabolic syndrome in US adolescents: cross-sectional analysis of the National Health and Nutrition Examination Survey. Public Health Nutr. 2016 (2005-2012), 1–11.
2. [2] Weiss, R., Bremer, A.A., Lustig, R.H., What is metabolic syndrome, and why are children getting it?. Ann. N. Y. Acad. Sci. 1281 (2013), 123–140.
3. [3] Bantle, J.P., Dietary fructose and metabolic syndrome and diabetes. J. Nutr. 139 (2009), 1263S–1268S.
4. [4] Price, D.L., Rhett, P.M., Thorpe, S.R., Baynes, J.W., Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 276 (2001), 48967–48972.
5. [5] Fu, M.X., Wells-Knecht, K.J., Blackledge, J.A., Lyons, T.J., Thorpe, S.R., Baynes, J.W., Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43 (1994), 676–683.
6. [6] Monnier, V.M., Taniguchi, N., Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication. Glycoconj. J., 2016.
7. [7] Sell, D.R., Monnier, V.M., Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology 58 (2012), 227–237.
8. [8] Bracesco, N., Sanchez, A.G., Contreras, V., Menini, T., Gugliucci, A., Recent advances on Ilex paraguariensis research: minireview. J. Ethnopharmacol. 136 (2011), 378–384.
9. [9] Gugliucci, A., Bastos, D.H., Schulze, J., Souza, M.F., Caffeic and chlorogenic acids in Ilex paraguariensis extracts are the main inhibitors of AGE generation by methylglyoxal in model proteins. Fitoterapia 80 (2009), 339–344.
10. [10] Lunceford, N., Gugliucci, A., Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea. Fitoterapia 76 (2005), 419–427.
11. [11] Gugliucci, A., Menini, T., The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III. Life Sci. 72 (2002), 279–292.
12. [12] DeChristopher, L.R., Uribarri, J., Tucker, K.L., Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years. Nutr. Diabetes, 6, 2016, e199.
13. [13] DeChristopher, L.R., Uribarri, J., Tucker, K.L., Intake of high fructose corn syrup sweetened soft drinks is associated with prevalent chronic bronchitis in U.S. adults, ages 20-55 y. Nutr. J., 14, 2015, 107.
14. [14] DeChristopher, L.R., Excess free fructose and childhood asthma. Eur. J. Clin. Nutr., 69, 2015, 1371.
15. [15] DeChristopher, L., Consumption of Fructose and High Fructose Corn Syrup: Is Fructositis Triggered Bronchitis, Arthritis, & Auto-Immune Reactivity Merely a Side Bar in the Etiology of Metabolic Syndrome II (to be Defined)? – Evidence and a Hypothesis. (MSc thesis), 2012, New York Medical College Library, Valhalla, NY.
16. [16] Uribarri, J., del Castillo, M.D., de la Maza, M.P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macias-Cervantes, M.H., Markowicz Bastos, D.H., Medrano, A., Menini, T., Portero-Otin, M., Rojas, A., Sampaio, G.R., Wrobel, K., Wrobel, K., Garay-Sevilla, M.E., Dietary advanced glycation end products and their role in health and disease. Adv. Nutr. 6 (2015), 461–473.
17. [17] Vlassara, H., Cai, W., Tripp, E., Pyzik, R., Yee, K., Goldberg, L., Tansman, L., Chen, X., Mani, V., Fayad, Z.A., Nadkarni, G.N., Striker, G.E., He, J.C., Uribarri, J., Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. Diabetologia 59 (2016), 2181–2192.
18. [18] Uribarri, J., Cai, W., Ramdas, M., Goodman, S., Pyzik, R., Chen, X., Zhu, L., Striker, G.E., Vlassara, H., Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34 (2011), 1610–1616.
19. [19] Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G.E., Vlassara, H., Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 110 (2010), 911–916 (e12).
20. [20] Ebert, K., Witt, H., Fructose malabsorption. Mol. Cell Pediatr., 3, 2016, 10.
21. [21] DiNicolantonio, J.J., Lucan, S.C., Is fructose malabsorption a cause of irritable bowel syndrome?. Med. Hypotheses 85 (2015), 295–297.
22. [22] Biesiekierski, J.R., Fructose-induced symptoms beyond malabsorption in FGID. U. Eur. Gastroenterol. J. 2 (2014), 10–13.
23. [23] Putkonen, L., Yao, C.K., Gibson, P.R., Fructose malabsorption syndrome. Curr. Opin. Clin. Nutr. Metab. Care 16 (2013), 473–477.
24. [24] Chen, Y.J., Liang, L., Liu, X.M., Labuza, T.P., Zhou, P., Effect of fructose and glucose on glycation of beta-lactoglobulin in an intermediate-moisture food model system: analysis by liquid chromatography-mass spectrometry (LC-MS) and data-independent acquisition LC-MS (LC-MS(E)). J. Agric. Food Chem. 60 (2012), 10674–10682.
25. [25] Oimomi, M., Sakai, M., Ohara, T., Igaki, N., Nakamichi, T., Hata, F., Baba, S., Acceleration of fructose mediated collagen glycation. J. Int. Med. Res. 17 (1989), 249–253.
26. [26] Oimomi, M., Nakamichi, T., Ohara, T., Sakai, M., Igaki, N., Hata, F., Baba, S., Fructose-related glycation. Diabetes Res. Clin. Pract. 7 (1989), 137–139.
27. [27] Del Rio, D., Stalmach, A., Calani, L., Crozier, A., Bioavailability of coffee chlorogenic acids and green tea flavan-3-ols. Nutrients 2 (2010), 820–833.
28. [28] Fernandez-Gomez, B., Ullate, M., Picariello, G., Ferranti, P., Mesa, M.D., del Castillo, M.D., New knowledge on the antiglycoxidative mechanism of chlorogenic acid. Food Funct. 6 (2015), 2081–2090.
29. [29] Menini, T., Heck, C., Schulze, J., de Mejia, E., Gugliucci, A., Protective action of Ilex paraguariensis extract against free radical inactivation of paraoxonase-1 in high-density lipoprotein. Planta Med. 73 (2007), 1141–1147.
30. [30] DeChristopher, L.R., Uribarri, J., Tucker, K.L., The link between soda intake and asthma: science points to the high-fructose corn syrup, not the preservatives: a commentary. Nutr. Diabetes, 6, 2016, e234.
31. [31] Touaibia, M., Jean-Francois, J., Doiron, J., Caffeic acid, a versatile pharmacophore: an overview. Mini-Rev. Med. Chem. 11 (2011), 695–713.
32. [32] Liang, N., Kitts, D.D., Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients, 8, 2015.
33. [33] Upadhyay, R., Mohan Rao, L.J., An outlook on chlorogenic acids-occurrence, chemistry, technology, and biological activities. Crit. Rev. Food Sci. Nutr. 53 (2013), 968–984.
34. [34] Meng, S., Cao, J., Feng, Q., Peng, J., Hu, Y., Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid. Based Complement. Alternat. Med., 2013, 2013, 801457.
35. [35] Gugliucci, A., Advanced glycation of rat liver histone octamers: an in vitro study. Biochem. Biophys. Res. Commun. 203 (1994), 588–593.
36. [36] Gugliucci, A., Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Adv. Nutr. 8 (2016), 1–9, 10.3945/an.116.013912.